Stay updated on Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New features have been added to the website, while several options related to data downloads and study details have been removed.
    Difference
    9%
    Check dated 2024-11-23T04:38:17.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Several key health-related resources, including MedlinePlus and FDA links, have been removed, which may impact access to important genetic and medical information.
    Difference
    1%
    Check dated 2024-11-15T23:49:46.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resources related to genetics, breast cancer, and drug information, while removing the previous version 2.12.1.
    Difference
    12%
    Check dated 2024-11-08T18:25:07.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.2%
    Check dated 2024-11-01T10:47:29.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.4%
    Check dated 2024-10-25T00:44:05.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.2%
    Check dated 2024-10-03T04:59:07.000Z thumbnail image

Stay in the know with updates to Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.